


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-5.55%
-23.69%
+2.84%
+13.95%
+2.43%
BDX
Becton, Dickinson and
$210.02
Strengths

Earnings are forecast to grow
Risk Analysis

Trading above its fair value
BDX Price Performance
$201.52 (+4.22%)
$188.97 (+11.14%)
$185.94 (+12.95%)
$230.31 (-8.81%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading above its fair value
![]()
BDX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
BDX Street Sentiment is extremely bullish and have positive views on the near-term outlook
BDX has Low risk level

Average key support and resistance price levels
Recent Upgrades and Downgrades
NEUTRAL
Date
Action
Rating
Firm
Dec 03, 2025
Reiterate
Overweight
Morgan Stanley
Nov 08, 2025
Reiterate
Neutral
Piper Sandler
BSX
Boston Scientific
76.27
-1.76%
TFX
Teleflex Incorporate
108.42
+2.40%
RMD
ResMed
271.63
+1.72%
IRTC
iRhythm Technologies
146.47
-0.19%
What is BDX current stock price?
What are BDX stock strengths?
What is BDX Risk Level?
What is BDX market cap and volume?
What is BDX current Stock IQ?
Should I buy BDX stock right now?
Is BDX a Strong Buy right now?
What does a 'Strong Buy' rating mean for BDX?
What does a 'Strong Sell' rating mean for BDX?
What factors influence BDX's Stock IQ?
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-5.55%
-23.69%
+2.84%
+13.95%
+2.43%
BDX
Becton, Dickinson and
Current Price
$210.02
Runners Also Watch
BSX
Boston Scientific
76.27
-1.76%
TFX
Teleflex Incorporate
108.42
+2.40%
RMD
ResMed
271.63
+1.72%
IRTC
iRhythm Technologies
146.47
-0.19%

BDX Price Performance
$201.52 (+4.22%)
$188.97 (+11.14%)
$185.94 (+12.95%)
$230.31 (-8.81%)
BDX Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading above its fair value
![]()
BDX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
BDX Street Sentiment is extremely bullish and have positive views on the near-term outlook
BDX has Low risk level

Average key support and resistance price levels
Overall Wall Street Rating
NEUTRAL
Dec 03, 2025
Reiterate
Overweight
Morgan Stanley
Nov 08, 2025
Reiterate
Neutral
Piper Sandler
BDX Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow
Risk Analysis

Trading above its fair value
BDX Latest Analysis
Watts Water (WTS) Carrying a Favorable Sentiment After Becton Dickinson Deal. Watts Water Technologies (NYSE:WTS) is one of the 15 best Industrial Machinery and Supplies stocks to buy according to Hedge Funds. On January 27 HSBC analyst Sidharth Sahoo initiated coverage of Watts Water (NYSE: WTS) assigning a Buy rating and a $460 price target. This results in a potential upside of nearly 51% from the [….]
Fri Feb 6, 2026
Countdown to Becton Dickinson (BDX) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS. Get a deeper insight into the potential performance of Becton Dickinson (BDX) for the quarter ended December 2025 by going beyond Wall Streets top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Wed Feb 4, 2026
Earnings Preview: Becton Dickinson (BDX) Q1 Earnings Expected to Decline. Becton Dickinson (BDX) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mon Feb 2, 2026
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.
Tue Jan 27, 2026
Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Mon Jan 26, 2026
BDX Stock Slides 2% After Company Unveils AI-Powered Research Platform . (RTTNews) - Becton Dickinson and Company (BDX) shares fell 2.46% to $200.98 down $5.06 after the company announced the launch of new AI-powered tools to advance immunology and cancer research.
Fri Jan 23, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.